KOS PHARMACEUTICALS INC (KOSP) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 93 transactions totaling $5.6M, demonstrating a bearish sentiment with -$5.6M in net insider flow. The most recent transaction on Dec 13, 2006 involved a transaction of 5,000 shares valued at $390.0K.
No significant insider buying has been recorded for KOSP in the recent period.
No significant insider selling has been recorded for KOSP in the recent period.
Based on recent SEC filings, insider sentiment for KOSP is bearish with an Insider Alignment Score of 0/100 and a net flow of -$5.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at KOS PHARMACEUTICALS INC (KOSP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading KOSP stock, having executed 93 transactions in the past 90 days. The most active insider is Michael Jaharis (Executive), who has made 11 transactions totaling $1.3B.
Get notified when executives and directors at KOSP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 13, 2006 | B. Whittemore Frederick | Executive | Tender | 5,000 | $78.00 | $390.0K | |
| Dec 13, 2006 | Brademas John | Executive | Tender | 5,000 | $78.00 | $390.0K | |
| Dec 13, 2006 | Ferro Kevin | Executive | Tender | 5,270 | $78.00 | $411.1K | |
| Dec 13, 2006 | M. D. Novitch Mark | Executive | Tender | 7,000 | $78.00 | $546.0K | Large |
| Dec 13, 2006 | E. Madias Nicholaos | Executive | Tender | 5,000 | $78.00 | $390.0K | |
| Dec 13, 2006 | D. Pruitt William | Executive | Tender | 5,000 | $78.00 | $390.0K | |
| Dec 13, 2006 | Adams Adrian | Executive | Tender | 33,304 | $78.00 | $2.6M | Large |
| Dec 13, 2006 | I. Koven Andrew | Executive | Tender | 10,336 | $78.00 | $806.2K | Large |
| Dec 13, 2006 | M. Bell Daniel | Executive | Tender | 45,998 | $78.00 | $3.6M | Large |
| Dec 13, 2006 | F. Rodriguez Juan | Executive | Tender | 9,576 | $78.00 | $746.9K | Large |
| Dec 13, 2006 | P. Clarke Kevin | Executive | Tender | 8,416 | $78.00 | $656.4K | Large |
| Dec 13, 2006 | E. Mcgovern Mark | Executive | Tender | 14,633 | $78.00 | $1.1M | Large |
| Dec 13, 2006 | E. Baldini Robert | Executive | Tender | 8,028 | $78.00 | $626.2K | Large |
| Dec 13, 2006 | Rosskamp Ralf | Executive | Tender | 9,818 | $78.00 | $765.8K | Large |
| Dec 13, 2006 | Jaharis Michael | Executive | Tender | 1,420,001 | $78.00 | $110.8M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 29 | $2.7B | 66.6% |
Other(J) | 4 | $1.3B | 33.2% |
Sale(S) | 17 | $5.6M | 0.1% |
Exercise(M) | 15 | $2.2M | 0.1% |
Gift(G) | 11 | $0 | 0.0% |
Award(A) | 17 | $0 | 0.0% |
Insider selling pressure at KOS PHARMACEUTICALS INC has increased, with 23 insiders executing 93 transactions across all time. Total sales of $5.6M significantly outpace purchases of $0, resulting in a net outflow of $5.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.